215 related articles for article (PubMed ID: 10868529)
1. Helicobacter pylori treatment and antibiotic susceptibility: results of a five-year audit.
Fraser AG; Moore L; Hackett M; Hollis B
Aust N Z J Med; 1999 Aug; 29(4):512-6. PubMed ID: 10868529
[TBL] [Abstract][Full Text] [Related]
2. Clinical evaluation of a ten-day regimen with esomeprazole, metronidazole, amoxicillin, and clarithromycin for the eradication of Helicobacter pylori in a high clarithromycin resistance area.
Georgopoulos SD; Xirouchakis E; Martinez-Gonzalez B; Sgouras DN; Spiliadi C; Mentis AF; Laoudi F
Helicobacter; 2013 Dec; 18(6):459-67. PubMed ID: 23714140
[TBL] [Abstract][Full Text] [Related]
3. Nonbismuth quadruple (concomitant) therapy: empirical and tailored efficacy versus standard triple therapy for clarithromycin-susceptible Helicobacter pylori and versus sequential therapy for clarithromycin-resistant strains.
Molina-Infante J; Pazos-Pacheco C; Vinagre-Rodriguez G; Perez-Gallardo B; Dueñas-Sadornil C; Hernandez-Alonso M; Gonzalez-Garcia G; Mateos-Rodriguez JM; Fernandez-Bermejo M; Gisbert JP
Helicobacter; 2012 Aug; 17(4):269-76. PubMed ID: 22759326
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of resistance to clarithromycin and its clinical impact on the efficacy of Helicobacter pylori eradication.
Ellenrieder V; Boeck W; Richter C; Marre R; Adler G; Glasbrenner B
Scand J Gastroenterol; 1999 Aug; 34(8):750-6. PubMed ID: 10499474
[TBL] [Abstract][Full Text] [Related]
5. [new one-week triple therapies with metronidazole for the eradication of Helicobacter pylori: clarithromycin or amoxycillin as the second antibiotic].
Gisbert JP; Boixeda D; Martín de Argila C; Redondo C; Moreno L; Abraira V; García Plaza A
Med Clin (Barc); 1998 Jan; 110(1):1-5. PubMed ID: 9527978
[TBL] [Abstract][Full Text] [Related]
6. Antibiotic susceptibility of Helicobacter pylori in Iceland.
Gunnarsdottir AI; Gudjonsson H; Hardardottir H; Jonsdottir KD; Bjornsson ES
Infect Dis (Lond); 2017 Sep; 49(9):647-654. PubMed ID: 28440099
[TBL] [Abstract][Full Text] [Related]
7. Helicobacter pylori eradication therapy outcome according to clarithromycin susceptibility testing in Japan.
Horie R; Handa O; Ando T; Ose T; Murakami T; Suzuki N; Sendo R; Imamoto E; Itoh Y
Helicobacter; 2020 Aug; 25(4):e12698. PubMed ID: 32368846
[TBL] [Abstract][Full Text] [Related]
8. Treatment regimens for Helicobacter pylori infection in children: is in vitro susceptibility testing helpful?
Faber J; Bar-Meir M; Rudensky B; Schlesinger Y; Rachman E; Benenson S; Sirota G; Stankiewic H; Halle D; Wilschanski M
J Pediatr Gastroenterol Nutr; 2005 May; 40(5):571-4. PubMed ID: 15861018
[TBL] [Abstract][Full Text] [Related]
9. The impact of primary antibiotic resistance on the efficacy of ranitidine bismuth citrate- vs. omeprazole-based one-week triple therapies in H. pylori eradication--a randomised controlled trial.
Bago J; Halle ZB; Strinić D; Kućisec N; Jandrić D; Bevanda M; Tomić M; Bilić A
Wien Klin Wochenschr; 2002 Jun; 114(12):448-53. PubMed ID: 12422579
[TBL] [Abstract][Full Text] [Related]
10. What can be learnt from the new data about antibiotic resistance? Are there any practical clinical consequences of Helicobacter pylori antibiotic resistance?
Bazzoli F; Berretti D; De Luca L; Nicolini G; Pozzato P; Fossi S; Zagari M
Eur J Gastroenterol Hepatol; 1999 Aug; 11 Suppl 2():S39-42; discussion S43-5. PubMed ID: 10503822
[TBL] [Abstract][Full Text] [Related]
11. The importance of the level of metronidazole resistance for the success of Helicobacter pylori eradication.
Wheeldon TU; Granström M; Hoang TT; Phuncarg DC; Nilsson LE; Sörberg M
Aliment Pharmacol Ther; 2004 Jun; 19(12):1315-21. PubMed ID: 15191514
[TBL] [Abstract][Full Text] [Related]
12. The impact of antibiotic resistance on the efficacy of three 7-day regimens against Helicobacter pylori.
Savarino V; Zentilin P; Pivari M; Bisso G; Raffaella Mele M; Bilardi C; Borro P; Dulbecco P; Tessieri L; Mansi C; Borgonovo G; De Salvo L; Vigneri S
Aliment Pharmacol Ther; 2000 Jul; 14(7):893-900. PubMed ID: 10886045
[TBL] [Abstract][Full Text] [Related]
13. High prevalence of Helicobacter pylori infection with dual resistance to metronidazole and clarithromycin in Hong Kong.
Wang WH; Wong BC; Mukhopadhyay AK; Berg DE; Cho CH; Lai KC; Hu WH; Fung FM; Hui WM; Lam SK
Aliment Pharmacol Ther; 2000 Jul; 14(7):901-10. PubMed ID: 10886046
[TBL] [Abstract][Full Text] [Related]
14. The relationship between consumption of antimicrobial agents and the prevalence of primary Helicobacter pylori resistance.
Perez Aldana L; Kato M; Nakagawa S; Kawarasaki M; Nagasako T; Mizushima T; Oda H; Kodaira J; Shimizu Y; Komatsu Y; Zheng R; Takeda H; Sugiyama T; Asaka M
Helicobacter; 2002 Oct; 7(5):306-9. PubMed ID: 12390210
[TBL] [Abstract][Full Text] [Related]
15. Reverse sequential therapy achieves a similar eradication rate as standard sequential therapy for Helicobacter pylori eradication: a randomized controlled trial.
Tsay FW; Wu DC; Kao SS; Tsai TJ; Lai KH; Cheng JS; Chan HH; Wang HM; Tsai WL; Tseng HH; Peng NJ; Hsu PI
Helicobacter; 2015 Feb; 20(1):71-7. PubMed ID: 25495272
[TBL] [Abstract][Full Text] [Related]
16. Concomitant therapy achieved the best eradication rate for Helicobacter pylori among various treatment strategies.
Lee HJ; Kim JI; Lee JS; Jun EJ; Oh JH; Cheung DY; Chung WC; Kim BW; Kim SS
World J Gastroenterol; 2015 Jan; 21(1):351-9. PubMed ID: 25574111
[TBL] [Abstract][Full Text] [Related]
17. Tailored versus Triple plus Bismuth or Concomitant Therapy as Initial Helicobacter pylori Treatment: A Randomized Trial.
Zhou L; Zhang J; Song Z; He L; Li Y; Qian J; Bai P; Xue Y; Wang Y; Lin S
Helicobacter; 2016 Apr; 21(2):91-9. PubMed ID: 26104022
[TBL] [Abstract][Full Text] [Related]
18. Eradication rate of Helicobacter Pylori infection is directly influenced by adherence to therapy in children.
Kotilea K; Mekhael J; Salame A; Mahler T; Miendje-Deyi VY; Cadranel S; Bontems P
Helicobacter; 2017 Aug; 22(4):. PubMed ID: 28303625
[TBL] [Abstract][Full Text] [Related]
19. Effects of primary metronidazole and clarithromycin resistance to Helicobacter pylori on omeprazole, metronidazole, and clarithromycin triple-therapy regimen in a region with high rates of metronidazole resistance.
Wong WM; Gu Q; Wang WH; Fung FM; Berg DE; Lai KC; Xia HH; Hu WH; Chan CK; Chan AO; Yuen MF; Hui CK; Lam SK; Wong BC
Clin Infect Dis; 2003 Oct; 37(7):882-9. PubMed ID: 13130398
[TBL] [Abstract][Full Text] [Related]
20. Role of MIC levels of resistance to clarithromycin and metronidazole in Helicobacter pylori eradication.
De Francesco V; Zullo A; Fiorini G; Saracino IM; Pavoni M; Vaira D
J Antimicrob Chemother; 2019 Mar; 74(3):772-774. PubMed ID: 30476134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
